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Cycads, Flying Foxes, and Brain Disease in Humans 
Logan Disney 
Introduction 
Cycads are seed plants with stout, woody trunks and a crown of large, stiff evergreen leaves 
existing within tropical and subtropical regions of the world (Chamberlain, 1993). Cycads 
dominated forest areas from around 250 million years ago to around 65 million years ago and are 
among the most primitive of today’s seed plants; however, all extant cycads evolved within the 
last 50 million years (Vessey, Pawlowski, & Bergman, 2004). All extant cycads belong to the 
families Cycadaceae, Stangeriaceae, and Zamiaceae, and they participate in a symbiotic 
relationship with nitrogen-fixing cyanobacteria (Thajuddin et al., 2010). These cyanobacteria 
release compounds that, in addition to the cycad’s own toxins, can have neurotoxic effects if 
consumed in sufficient doses. Though they have long been known to be toxic, cycad seeds are 
eaten by humans after being washed and processed in an effort to remove the toxins. Cycad 
seeds also make up a significant portion of the diet of some flying foxes. “Flying fox” is a 
colloquial name referring to a bat of the genus Pteropus or the closely related Acerodon (De Jong 
et al., 2013). They are a type of fruit-eating bat and are the largest bats in the world. They are 
considered a delicacy in some regions and have been threatened by overhunting and 
deforestation. Several species have gone extinct due to human activity. Flying foxes often share a 
habitat with cycads, particularly in Old World tropical and subtropical regions such as the Pacific 
Islands. Heavy consumption of cycad seeds leads to accumulation of toxic chemicals in the 
tissues of flying foxes. Toxicity resulting from the consumption of cycads and flying foxes is 
hypothesized to be a cause of significant neurological abnormality in humans including a severe 
progressive neurodegenerative disease known as the amyotrophic lateral sclerosis and 
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parkinsonism-dementia complex, or ALS-PDC (Spencer, Lasarev, Palmer, & Kisby, 2010). For 
much of the twentieth century, incidence of ALS-PDC was far greater in tropical regions in 
which cycads and flying foxes were common dietary items (Kurland & Mulder, 1954). For 
example, the Chamorro people of Guam have traditionally consumed significant amounts of 
cycads and flying foxes. The Chamorro also once had one of the highest known incidence rates 
of ALS-PDC ever known, up to 200 cases per 100,000 people. The name of this disease reflects 
the similarity of symptoms and neuropathology found in people suffering from ALS-PDC to that 
of people afflicted with each of its namesake diseases—amyotrophic lateral sclerosis, abnormal 
Parkinson’s disease, and dementia and Alzhiemer’s disease (Kuzuhara et al., 2001). Ethnic 
groups in which ALS-PDC was once extraordinarily frequent have seen a sharp decline in 
diagnoses upon reduction in their consumption of cycads and cycad-toxin-biomagnifying flying 
foxes as they conform to modern life (Monson, Banack, & Cox, 2003). 
 
Interspecies Relationships 
There are numerous interspecies interactions that must be considered in order to fully understand 
the relationships between cycads, flying foxes, and humans and the effects of these interactions 
on the participants.  
 
Cycads and Cyanobacteria 
Cyanobacteria are unusual among prokaryotes in that they possess the capacity to perform 
photosynthesis—in fact, the prevailing hypothesis on the origin of plant chloroplasts is an early 
endosymbiotic event in which a cyanobacterium was taken up by a Eukaryotic cell (Raven & 
Allen, 2003). Most cyanobacteria are also diazotrophic, which means they are able to fix 
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atmospheric nitrogen (N2) into a usable form (Fay, 1992). Cyanobacteria are an important source 
of fixed nitrogen in many ecosystems. They commonly fix nitrogen as free-living organisms or 
within symbiotic relationships with a variety of fungi and plants (Vitousek et al., 2002). The only 
known gymnosperms to participate in nitrogen fixation with cyanobacteria are cycads 
(Thajuddin et al., 2010). It is thought that the relationship between cycads and cyanobacteria 
began to develop during the time in which cycads dominated the world as early as 250 million 
years ago. 
 
Cycads associate with nitrogen-fixing cyanobacteria within specialized roots known as coralloid 
roots that extend in branches above the ground or at shallow depths. The association of cycads 
with cyanobacteria within specialized plant structures represent a truly mutualistic form of 
nitrogen fixation (Vessey et al., 2004). This contrasts with the more common opportunistic type 
of relationship in which free-living nitrogen-fixing bacteria release fixed nitrogen (usually in the 
form of ammonia) into the environment, and this environmental nitrogen is subsequently taken 
up by plants. The endophytic cyanobacteria that infect the coralloid roots of cycads are almost 
entirely found within the genera Nostoc or Anabaena, though it is believed that the strains of 
Anabaena participating in nitrogen-fixation symbiotic relationships with cycads would be re-
designated as members of Nostoc if their taxonomy were to be re-evaluated with improved 
criteria (Rippka, Deruells, Waterbury, Herdman, & Stanier, 1979). The cyanobacteria are 
believed to enter the coralloid root through breaks in the root’s dermal layers within the soil 
(Milindasuta, 1975). Several species of cyanobacteria can be found within a single cycad 
(Lindblad, Haselkorn, Bergman, & Nierzwicki-Bauer, 1989). Cells within the endophyte cavity 
of the coralloid root possess numerous outgrowths, abundant mitochondria, and many secretory 
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granules outside the plasma membrane but within the cell wall. These structures grant the cycad 
the ability to quickly and efficiently exchange nutrients with the nitrogen-fixing cyanobacteria, 
reflecting the cycad’s adaptation to facilitate the symbiotic relationship. Within a single coralloid 
root, a single species of cyanobacteria will outcompete all others, but different coralloid roots 
within a single plant can host distinct species (Costa, Paulsrud, & Lindblad, 1999). Like other 
diazotrophs, cyanobacteria possess a nitrogenase enzyme that ultimately converts atmospheric 
nitrogen (N2) into ammonia (NH3) in a process that requires the cleavage of the triple bond 
between the two nitrogen atoms in diatomic atmospheric nitrogen (C. Lee, Ribbe, & Hu, 2014). 
This process requires energy input and is coupled to substantial input of ATP (16 molecules of 
ATP are required for every molecule of N2 converted into 2 NH3) (C. Lee et al., 2014). The 
relationship between cyanobacteria and cycads is mutualistic in that cyanobacteria obtain ATP to 
carry out nitrogen fixation and other cellular processes, while cycads obtain a ready source of 
usable nitrogen. 
 
A consequence of the relationship between cycads and cyanobacteria is the accumulation in 
cycad tissues of Β-methylamino-ʟ-alanine, or BMAA, a neurotoxic non-proteinogenic amino 
acid secreted by many species of cyanobacteria. While cycads produce toxins of their own, 
BMAA is the most well-researched of the cycad-involved toxins and has been suggested as a 
possible cause of ALS-PDC.  
 
Cycads and Flying Foxes 
Flying foxes and cycads participate in a typical seed dispersal relationship. Bats are involved in 
seed dispersal with many fruit-bearing organisms and have been shown to be quite effective seed 
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dispersers (Medellin & Gaona, 1999). Animal seed dispersal in cycads is not a heavily-
researched topic, but bats were one of the first organisms described to disperse cycad seeds (Pijl, 
1957). The bats are attracted to brightly colored seeds displayed by the cycad and consume the 
fleshy, edible outer layer (sarcotesta) before discarding the remainder of the seed elsewhere, still 
capable of germination. While the sarcotesta contains a relatively small quantity of BMAA, 
consumption of many seeds and inadvertent consumption of other seed parts leads to the 
accumulation of BMAA in flying fox tissues. This accumulation results in such biomagnification 
of BMAA that consumption of a single flying fox by humans could give a dose of BMAA 
comparable to consumption of 174 to 1,014 kilograms of processed cycad flour (Banack & Cox, 
2003). 
 
While cycads and flying foxes participate in a mutualistic interaction, it is unlikely that 
substantial co-evolution has taken place because neither organism depends on the other. Cycad 
seeds are only one of many sources of nutrients for flying foxes, and cycad seeds are often 
dispersed by other animals including possums (Ballardie & Whelan, 1986). 
 
Cycads and Humans 
The fact that cycad seeds have been long known to contain toxins has not prevented humans 
from finding ways to consume them. The Chamorro people of Guam traditionally made tortillas 
and flour using ground cycad seeds. Other food items such as dumplings and thick soups were 
also commonly produced from cycad seeds. The Chamorro were aware of the neurotoxic effects 
of raw cycad seeds and developed methods to remove the toxins. Cycad seeds were washed in 
water over the course of days or weeks with repeated changing of the wash water. BMAA and 
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other toxins have been shown experimentally to dissociate from the seed as a result of these 
water washes, although researchers have stated that the use of a less polar solvent such as ethanol 
would be more effective (Spencer et al., 2010). The Chamorro believed the seeds were safe to eat 
when “their chickens didn’t die after drinking the wash water (Holtcamp, 2012).” Rather than 
risk losing chickens, some Chamorro stop washing the seeds when the “urine-like smell vanishes 
(Banack, Murch, & Cox, 2006).” While BMAA has been shown to lead to neurodegeneration 
and symptoms similar to ALS-PDC in animal models, the hypothesis that BMAA toxicity from 
consumption of cycad seed-derived food products was briefly contested when it was reported 
that the Chamorro washing procedure removed a sufficient amount of free BMAA to eliminate 
the possibility of obtaining a toxic dose through eating seed-derived products (Duncan, Steele, 
Kopin, & Markey, 1990). However, this conclusion was based on findings that most free BMAA 
was successfully extracted by the washes. It was discovered in 2009 that a substantial amount of 
additional BMAA exists in protein-bound form within cycad seeds, and this protein-bound 
BMAA is not removed by Chamorro-like washing patterns; therefore, previous studies likely 
underestimated the amount of BMAA consumed in cycad seed-derived food products (Cheng & 
Banack, 2009). Therefore, BMAA toxicity through cycad seed consumption cannot be ruled out 
as a possible cause of ALS-PDC. 
 
Flying Foxes and Humans 
Flying foxes are a traditional food item of several cultures within their territory. Flying fox meat 
is considered a delicacy in Polynesia and Indonesia (Wheeler, 1979). The Chamorro people of 
Guam, however, are more invested with flying fox consumption to the point at which “many 
Chamorros believe that the consumption of flying foxes is central to their cultural identity 
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(Banack et al., 2006).”  The effect of human consumption of fruit bats on fruit bat populations 
was significantly worsened in the twentieth century. Changes in trade and technology increased 
the efficiency of flying fox hunting. Essentially, flying foxes were once considered an occasional 
treat, hunted at a subsistence level using hand nets (Linsley, 1934). They began to be hunted with 
firearms and traded for profit. In addition to increased popularity and hunting efficiency, other 
human activity such as deforestation negatively impacted populations of flying fox. Due to 
cultural pushback, flying foxes were not protected promptly and effectively until after the 
extinction of some species and endangerment of others (Wheeler, 1979). An illegal flying fox 
trade persisted for some time, and still exists to some degree, but is limited by a distinct lack of 
flying foxes to hunt. 
 
The Chamorro people of Guam prepare and eat flying foxes in their entirety. They are strewed 
with water, vegetables, coconut milk, and MSG, and are then wholly consumed—meat, organs, 
fur and all (Banack et al., 2006). They are commonly prepared for special occasions and served 
along with cycad tortillas. Prior to the discovery that many studies had underestimated the 
amount of BMAA present within washed cycad seeds (Cheng & Banack, 2009), the BMAA 
hypothesis for ALS-PDC was contested due to the finding that a person could not obtain a 
sufficient dose to produce symptoms by eating cycad seed-derived foods (Duncan et al., 1990). 
The BMAA hypothesis was revitalized when it was discovered that flying foxes were shown to 
contain considerable quantities of either free BMAA, protein-bound BMAA, or both forms of 
BMAA in all body tissues (Banack et al., 2006). This was true in both raw flying fox tissues and 
flying fox tissues that were subjected to traditional Chamorro preparation. Flying foxes serve to 
biomagnify BMAA to such a degree that consumption of a single flying fox provides a 
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substantially higher dose of BMAA than a person could obtain from directly eating food 
prepared from cycad seeds (Banack et al., 2006). There are other commonly hunted local fauna 
such as deer and feral pigs that consume cycad seeds and are also thought to cause BMAA 
biomagnification, although they are not as well-studied as flying foxes.  
 
Neuropathology 
Patients suffering from the amyotrophic lateral sclerosis-parkinsonism dementia complex, or 
ALS-PDC, present with symptoms and neuropathology that overlap those characteristic of ALS, 
Parkinson’s Disease, and Alzheimer’s disease. Currently, a diagnosis of ALS-PDC cannot be 
confirmed until after death (McGeer & Steele, 2011). The disease’s three distinct namesake 
phenotypes tend to occur at different stages of life. It is uncommon for dementia to occur in 
affected individuals until they have reached an advanced age, while ALS symptoms can develop 
in adolescents or young adults. Parkinsonism most commonly appears during adulthood 
(McGeer & Steele, 2011). It is noteworthy that, like many neurodegenerative diseases, ALS-
PDC can manifest quite differently from patient-to-patient. Some experience little to no dementia 
and are capable of speech and rational thought even after they have become nearly paralyzed due 
to the disease’s effects on motor neurons, while others express dementia-related behavioral and 
emotional changes prior to significant loss of motor function (Steele, 2005).   
 
ALS-PDC and Alzheimer’s Disease 
A characteristic abnormality in the central nervous system shared by individuals with ALS-PDC 
and those with Alzheimer’s disease is the presence of neurofibrillary tangles (NFTs) in both 
neurons and glial cells due to aggregation of abnormal tau proteins. Properly functioning tau 
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proteins serve to stabilize microtubules in neurons of the central nervous system. Tau proteins 
are expressed at low levels in glial cells as well. In a disease known as a tauopathy, tau proteins 
function abnormally. Many tauopathies involve the hyperphosphorylation of tau, which inhibits 
tau binding and stabilization of microtubules and leads to the formation of large tau aggregates 
known as NFTs (H. Lee et al., 2005). Misfolded tau proteins can induce the aggregation of other 
tau proteins, so tauopathies are considered to progress in a prion-like manner (Krammer, Schätzl, 
& Vorberg, 2001). Autopsies reveal that NFTs are found in the cortical areas of individuals who 
were diagnosed with ALS-PDC to a much higher degree than those who were diagnosed with 
only ALS. This leads to the conclusion that NFTs in cortical regions of the brain are involved in 
the parkinsonism-dementia complex in ALS-PDC (Miklossy et al., 2005). Studies have also 
found deposits of the Alzheimer’s disease hallmark β-amyloid deposits within the brains of ALS-
PDC-diagnosed individuals (Cox, Banack, & Murch, 2003). In a manner similar to that by which 
misfolded tau leads to NFT, misfolded amyloid β proteins have a prion-like propagation leading 
to oligomerization and formation of plaques. β-amyloid plaques are believed to be the most toxic 
of the plaques that occur in Alzheimer’s disease (Zhao, Long, Mu, & Chew, 2012), so their 
detection in ALS-PDC may contribute to the disease’s severity. Furthermore, individuals who 
displayed more advanced symptoms of dementia showed reduced cortical thickness and 
reduction in the volume of basal nuclei (Wilson et al., 2004). It should be noted that some ALS-
PDC patients do not develop Alzheimer’s disease-like symptoms. It is uncertain whether this is 
more attributable to patients dying before reaching the late-in-life onset of dementia or a 
different underlying etiology for the non-dementia cases. Mood swings and memory loss are 




ALS-PDC and Parkinson’s Disease 
A pathological characteristic of ALS-PDC that is consistent with that of Parkinson’s disease is 
mutation in α-synuclein (Yamazaki et al., 2000). α-synuclein is an abundant soluble protein in 
the brain whose normal function is not known. Mutation of α-synuclein can lead to aggregation 
and loss of solubility. Mutant α-synuclein is the primary component of a Lewy body—a mass of 
insoluble protein aggregates that disrupt cellular function by displacing normal cell components 
(Schulz-Schaeffer, 2010). Several diseases can result from mutation in α-synuclein mutation and 
aggregation. These diseases are classified as synucleinopathies. It has been shown both in vitro 
and in vivo that synucleinopathies and tauopathies can interact with one another, worsening 
neurodegeneration in a “deleterious feed-forward loop (Moussaud et al., 2014).” ALS-PDC is an 
example of a disease expressing both tauopathic and synucleophathic pathology, which may 
contribute to the severity of the disease. In both ALS-PDC and Parkinson’s disease, Lewy body 
buildup in neurons of the central nervous system is associated with the death of these neurons, 
although the exact reason that Lewy body accumulation correlates with neuronal death is not yet 
understood (Kalia & Lang, 2015). While the motor effects of both diseases are highly variable 
from patient-to-patient, common symptoms include tremors, uncontrollable muscle tension, and 
spasms. These motor symptoms are primarily the result of neuronal death within the substantia 
nigra region of the midbrain (Dawson & Dawson, 2003). 
 
ALS-PDC and ALS 
The neuropathology and symptoms of ALS are almost entirely present in ALS-PDC. In both 
diseases, substantial loss of motor neurons can be seen in the spinal cords of autopsied 
individuals (Morris et al., 2001). A progressive decline in motor capabilities occurs in both 
11 
 
diseases. A biological marker shared by ALS and ALS-PDC is TDP-43 aggregation (Miklossy et 
al., 2005). Under normal conditions, TDP-43 is a DNA-binding protein that represses 
transcription of HIV-1 and controls alternative splicing of other genes (Kuo, Doudeva, Wang, 
Shen, & Yuan, 2009). In a diseased individual, TDP-43 is hyperphosphorylated and otherwise 
modified to yield “pathogenic TDP-43” which forms toxic aggregations. Cycad consumption is 
linked to the formation of TDP-43 aggregates through misincorporation of the non-proteinogenic 
amino acid β-methylamino-ʟ-alanine, present in cycad seeds, during translation (Dunlop, Cox, 
Banack, & Rodgers, 2013). 
 
Etiology 
The three most researched cycad toxins that have been named as potential causes for ALS-PDC 
are: β-methylamino-ʟ-alanine, or BMAA; methylazoxymethanol, or MAM, which is derived 
from cycasin; and β-sitosterol β-D-glucoside (BSSG). The most support in scientific literature 
has been provided for BMAA, although there have been times in which BMAA was largely 
rejected as a potential cause before being reinvigorated by new findings. While BMAA is 
thought to have multiple modes of neurotoxicity, all three of these toxins share one 
commonality: toxin-involved overstimulation of glutamate receptors leads to neuronal cell death. 
The potential neurotoxic effects of the three toxins should not be viewed as alternative 
hypotheses for the true one cause of ALS-PDC. It is possible that all these toxins, along with 
other factors such as genetic predisposition and age of exposure, contribute to the etiology of the 






β-methylamino-ʟ-alanine, or BMAA, is the most studied of the neurotoxins in cycad-related 
neurodegeneration. Structurally, BMAA differs from the normal, proteogenic protein alanine 
from which it is derived only by the addition of a methylamino group on the side chain. This 
chemical substitution results in a distinct change in chemical properties—while the side chain of 
alanine is small, nonpolar and hydrophobic, the side chain of BMAA has polar and basic 
properties. As a common cyanobacterial neurotoxic secretion, BMAA is not limited to cycad 
roots; it has been found in contaminated seafood and drinking water supplies as well (Holtcamp, 
2012). BMAA is a non-proteinogenic amino acid, meaning it is not one of the twenty amino 
acids that can be used by organisms to synthesize a polypeptide chain during protein synthesis. 
Although DNA transcription and mRNA translation are highly controlled mechanisms with 
specialized regulatory systems that help to prevent the addition of such abnormal amino acids to 
a polypeptide sequence, BMAA and other incorrect amino acids may be included in a protein at 
low error rates. For somatic cells, this is largely inconsequential because significantly affected 
cells can undergo apoptosis and be replaced before the abnormal proteins can create large-scale 
problems. However, neurons do not undergo such cellular replication. Abnormal proteins such as 
those resulting from BMAA inclusion can accumulate in these cells. For this reason, neurons are 
especially susceptible to the effects of BMAA toxicity. There are several neurotoxic effects that 
have been linked to BMAA exposure, leading to the hypothesis that BMAA exposure from 
cycad and flying fox consumption is to blame for the increased rate of ALS-PDC in the 




One mode of BMAA neurotoxicity involves improper inclusion of BMAA in polypeptide chains 
leading to improper protein folding. This can result in the exposure of normally interior 
hydrophobic amino acids, which are attracted to exposed hydrophobic amino acids in other 
misfolded proteins. These intermolecular attractions between hydrophobic amino acids in 
misfolded proteins result in the formation of small protein aggregates. Much like the propagation 
of prion proteins in prion diseases, abnormal proteins containing BMAA can induce the 
aggregation of other proteins. BMAA inclusion in polypeptides ultimately results in the 
formation of large, toxic protein aggregates that may disrupt cellular function (Krammer et al., 
2001). The hypothesis that BMAA-induced misfolding was the cause of its neurotoxic effects 
was criticized due to the high specificity of tRNA limiting the potential for a non-proteinogenic 
amino acid such as BMAA to be incorporated into a polypeptide chain. However, it was later 
discovered that BMAA can be mistaken for ʟ-serine by tRNA synthetase (Dunlop et al., 2013), 
giving it the potential to be misincorporated into proteins at a higher rate than previously 
thought. One specific protein that is particularly affected by BMAA misincorporation is TDP-43. 
As previously discussed, TDP-43 aggregates are often found in post-mortem brain examinations 
of people who died of amyotrophic lateral sclerosis (Igaz et al., 2011). 
 
BMAA’s role in neurotoxicity is not limited to improper incorporation into polypeptide chains. 
Direct exposure to unbound BMAA leads to substantial loss of motor neurons in spinal cord 
culture due to overstimulation of glutamate receptors (Rao, Banack, Cox, & Weiss, 2006) . 
Glutamate is an excitatory neurotransmitter whose overexpression can lead to toxic effects in 
neurons. Glutamate-mediated excitotoxicity is characteristic of other neurodegenerative diseases 
including Alzheimer’s disease (Hynd, Scott, & Dodd, 2004). BMAA-associated acute motor 
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neuron loss was prevented in cultures including NBQX, a glutamate receptor antagonist. In 
motor neurons, but not the remainder of spinal neurons, glutamate receptor overstimulation by 
BMAA induced a toxic increase in production of reactive oxygen species. Extended BMAA 
exposure depletes glutathione, an important antioxidant, which may worsen the effect of the 
upregulated reactive oxygen species on cells (Rush, Lie, & Lobner, 2012). Glutamate receptor 
overstimulation also leads to a substantial rise in intracellular calcium ion concentration (Rush et 
al., 2012), which has been shown to correlate with neuronal degeneration (Hartley, Kurth, 
Bjerkness, Weiss, & Choi, 1993). It is possible that the loss of spinal motor neurons resulting 
from overstimulation of glutamate receptors by BMAA plays a role in the ALS-like 
symptomology and pathology seen in most cases of ALS-PDC.  
 
Cycasin & MAM 
Unlike BMAA, cycasin is secreted by cycads themselves and not by a cyanobacterial endophyte. 
Cycasin is an azoxyglucoside that is readily hydrolyzed through metabolism to form glucose and 
methylazoxymethanol, or MAM. MAM is linked to carcinogenicity, hepatotoxicity, and 
neurodegeneration in humans (Wilson, Khabazian, & Wong, 2002). One-time exposure to MAM 
has been shown in animal models to lead to substantial DNA damage in the form of O6-
methyldeoxyguanosine lesions (Esclaire et al., 1999). As the name implies, these lesions involve 
improper methylation of guanine nucleotides at the O6 position of the nitrogenous base. This 
increases the likelihood of G:C-A:T mutations in DNA replication. It is believed that this occurs 
when DNA polymerases mistake the O6-methylguanine as an adenine nucleotide due to the 




The link to O6-methylguanine-induced DNA replication errors readily explains the 
carcinogenicity of MAM; if mutations continue to occur in certain signaling or replication 
mechanisms, uncontrolled cell proliferation could result and lead to tumor formation. It is less 
obvious how the DNA damage induced by MAM affects neurons of the central nervous system 
that do not undergo mitosis. Convincing evidence toward the etiology of ALS-PDC resulting 
from MAM toxicity was first presented in 2011, when unrepaired O6-methylation of neuronal 
DNA in young animal models was linked to activation of signaling pathways associated with 
neurodegeneration (Kisby et al., 2011). One such pathway involves upregulation of two distinct 
glutamate receptors. As discussed in previous sections, glutamate-mediated excitotoxicity is 
linked to neurodegeneration. These findings suggest that exposure to MAM through 
consumption of cycad-derived foods in early life may contribute to the development of the 
neurodegenerative ALS-PDC.  
 
BSSG 
Isolation of cycad seed compounds reveals that cycads contain numerous sterols (Marler & 
Shaw, 2009). One of these sterols, β-sitosterol β-D-glucoside (BSSG), has been shown in 
multiple animal models to have substantial neurotoxic effects (Wilson et al., 2002; Wilson, 
2005). β-sitosterol (BSS) is a widely distributed sterol that was never considered as a candidate 
for explaining cycad neurotoxicity due to its presence in many food items that are not linked to 
neurodegenerative disease, such as vegetable oil and nuts (Anderson & Nabenhauer, 1924). 
BSSG is a derivative of BSS that is rare in most organisms, but present in cycads. A 2002 study 
revealed that, when neurodegeneration was triggered in animal models through cycad 
consumption, the most toxic compound by some measures was BSSG; BMAA and MAM were 
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only found to be present in trace amounts (Wilson et al., 2002). The neurotoxicity in this study 
was quantified by measuring depolarizing field potentials leading to lactate dehydrogenase 
release. Lactate dehydrogenase is a known marker for cell turnover and has been described 
previously as useful for quantification of glutamate-mediated neuronal death (Koh & Choi, 
1987). It is noteworthy that BSSG was found to be more toxic than BMAA and MAM by a 
marker of neurotoxicity that is based upon glutamate-mediated neurotoxicity, considering that 
this is a proposed mechanism of neurotoxicity for both of these compounds as well (as discussed 
in previous sections). However, these studies took place prior to the finding that the methodology 
of previous studies likely underestimated BMAA quantities in tissues. 
 
Genetic Considerations 
ALS-PDC was quickly ruled out as a genetic disorder. While most cases occurred in certain 
populations, there are documented cases of people outside these populations contracting the 
disease in the same geographic location. For example, a Caucasian man contracted ALS-PDC 
after spending several years in Guam (Waring & Annegers, 1994). The fact that non-natives can 
develop ALS-PDC in the same geographic location led to the conclusion that ALS-PDC is 
primarily caused by environmental factors. However, while genetics are not the primary cause of 
ALS-PDC, there are genetic factors that have been linked to increased or decreased susceptibility 
to the disease. 
 
Apolipoprotein E (ApoE) is a protein in mammals that is involved in fat and cholesterol 
metabolism. It is produced by the liver for somatic tissues and produced by astrocytes for tissues 
of the central nervous system (Liu, Kanekiyo, Xu, & Bu, 2013). The ApoE that is secreted by 
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astrocytes is the primary carrier of cholesterol in the central nervous system (Puglielli, Tanzi, & 
Kovacs, 2003). ApoE is heavily researched as a risk factor for Alzheimer’s disease (Liu et al., 
2013). In some populations, those who express the E4 variant of E4 carry 10 to 30 times the risk 
for late-onset Alzheimer’s disease compared to the general population. In his 2005 dissertation, 
Wilson (2005) published experiments on two considerations of the potential role of ApoE in 
ALS-PDC. The first experiment sought to determine whether the presence or absence of ApoE 
affected neurodegeneration in cycad-fed mice. He found that ApoE knockout mice did not show 
the motor deficits that the ApoE wild type mice showed after being subjected to the same cycad-
rich diet. The second compared neurodegeneration in cycad-fed mice expressing different 
isoforms of ApoE: human E2, E3, and E4 isoforms, as well as mouse wild-type ApoE. This 
revealed that cycad-fed mice expressing human ApoE4 were particularly susceptible to motor 
deficits, while those expressing E2 were somewhat protected (although still affected). The results 
of these experiments indicate that ApoE plays some role in generating neurotoxicity from cycad 
toxins, and humans expressing the E4 variant of ApoE may be more susceptible. The exact 
mechanism is not known, although Wilson speculates that the cholesterol-carrying ApoE may 
contribute to entry and metabolism of BSSG, a neurotoxic sterol found in cycad seeds and 
discussed previously. 
 
Another genetic factor that has been suggested to affect susceptibility to ALS-PDC is variation in 
the microtubule associated protein tau gene, MAPT, which codes for the production of tau 
proteins. Alternative splicing of MAPT results in the potential for multiple forms of tau to be 
produced by the MAPT gene (Goedert, Wischik, Crowther, Walker, & Klug, 1988). MAPT 
variation has been shown to increase susceptibility to other neurodegenerative diseases such as 
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progressive supranuclear palsy (Conrad et al., 1999). A 2007 study comparing individuals 
diagnosed with ALS-PDC to control groups identified two independent sites of genetic variation 
within the MAPT gene that are associated with an increased risk of developing the disease 
(Sundar et al., 2007). 
 
Areas of Interest for Future Research 
Findings based on molecular data revealed that all extant cycads evolved within the last 50 
million years. Because all extant cycads possess coralloid roots to facilitate symbiosis with 
cyanobacteria, it is possible that these structures helped these extant cycads to survive extinction 
events, while any cycads that lacked coralloid roots died out. It is difficult to find literature on 
the evolutionary origin of coralloid roots. If possible, future morphological and molecular studies 
should be performed on cycad fossils to attempt to discover the point in cycad evolutionary 
history at which coralloid roots are first seen. 
 
More studies should be performed on biomagnification in mammals outside of flying foxes. If 
cycad seed-eating feral pigs, deer, or possums accumulate BMAA or other toxins within their 
tissues, consumption of these wild-caught animals should be avoided. 
 
As the exact mechanisms of toxicity are elusive for all neurodegenerative diseases, further 
studies should continue to seek to find the exact manner in which ALS-PDC and other diseases 
progress. Markers such as NFT, β-amyloid plaques, Lewy bodies, and TDP-43 aggregations are 
evidently associated, but it is not certain exactly how they cause toxicity or whether they are 
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actually toxic or simply a by-product of unknown toxic mechanisms. Studies to identify other 
genes that affect susceptibility to ALS-PDC should also be performed. 
 
Conclusion 
Cycads are ancient seed plants with a rich fossil history. Their association with nitrogen-fixing 
cyanobacteria contributes to some, but not all, of their well-known toxicity. Flying foxes and 
other cycad-fruit-eating mammals serve to biomagnify cycad toxins due to the accumulation of 
these toxins within the mammals’ tissues. Consumption of cycad-derived foods and flying foxes 
allows the effects of cycad toxins to manifest in humans and other animals. The interactions 
between cycads, cyanobacteria, flying foxes, and humans may lead to a severe 
neurodegenerative disease known as the amyotrophic lateral sclerosis and parkinsonism-
dementia complex, or ALS-PDC. Incidence of ALS-PDC has decreased accordingly with a 
decrease in cycad and flying fox consumption among populations that previously expressed 
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